HRP20070429T3 - Crystal form of asenapine maleate - Google Patents

Crystal form of asenapine maleate

Info

Publication number
HRP20070429T3
HRP20070429T3 HR20070429T HRP20070429T HRP20070429T3 HR P20070429 T3 HRP20070429 T3 HR P20070429T3 HR 20070429 T HR20070429 T HR 20070429T HR P20070429 T HRP20070429 T HR P20070429T HR P20070429 T3 HRP20070429 T3 HR P20070429T3
Authority
HR
Croatia
Prior art keywords
crystal form
asenapine maleate
asenapine
maleate
oxepino
Prior art date
Application number
HR20070429T
Other languages
English (en)
Croatian (hr)
Inventor
Johannes Heeres Gerhardus
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36617328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20070429(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20070429T3 publication Critical patent/HRP20070429T3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HR20070429T 2005-04-07 2007-09-19 Crystal form of asenapine maleate HRP20070429T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102742 2005-04-07
EP05102969 2005-04-14

Publications (1)

Publication Number Publication Date
HRP20070429T3 true HRP20070429T3 (en) 2007-11-30

Family

ID=36617328

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070429T HRP20070429T3 (en) 2005-04-07 2007-09-19 Crystal form of asenapine maleate

Country Status (31)

Country Link
EP (2) EP1710245B1 (pt)
JP (1) JP5058151B2 (pt)
KR (1) KR101422843B1 (pt)
AR (1) AR056306A1 (pt)
AT (2) ATE370954T1 (pt)
AU (1) AU2006231617B2 (pt)
BR (1) BRPI0609741A8 (pt)
CA (1) CA2603509C (pt)
CY (2) CY1106902T1 (pt)
DE (2) DE602006000080T2 (pt)
DK (2) DK1710245T3 (pt)
DO (1) DOP2006000082A (pt)
ES (2) ES2318742T3 (pt)
GT (1) GT200600135A (pt)
HN (1) HN2006014095A (pt)
HR (1) HRP20070429T3 (pt)
IL (1) IL186355A (pt)
MX (1) MX2007012445A (pt)
MY (1) MY137969A (pt)
NO (1) NO340520B1 (pt)
NZ (1) NZ562124A (pt)
PE (1) PE20061311A1 (pt)
PL (2) PL1710245T3 (pt)
PT (2) PT1710245E (pt)
RS (1) RS50532B (pt)
RU (1) RU2405786C2 (pt)
SI (2) SI1710245T1 (pt)
SV (1) SV2006002473A (pt)
TW (1) TWI364423B (pt)
UY (1) UY29459A1 (pt)
WO (1) WO2006106135A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2667668A1 (en) * 2006-10-06 2008-04-10 N.V. Organon Amorphous asenapine and processes for preparing same
CN102596172A (zh) * 2009-06-24 2012-07-18 Msd欧斯股份有限公司 含有阿塞那平的注射剂和使用其的治疗方法
US8779161B2 (en) 2010-06-18 2014-07-15 Dr. Reddy's Laboratories Limited Asenapine maleate
WO2012066565A2 (en) * 2010-11-16 2012-05-24 Cadila Healthcare Limited Asenapine maleate amorphous and crystalline form and process for preparation thereof
EP2468750A1 (en) 2010-12-13 2012-06-27 Chemo Ibérica, S.A. Polymorphic forms of asenapine maleate and processes for their preparation
WO2012123325A1 (en) 2011-03-11 2012-09-20 Medichem S.A. NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID
ITMI20110734A1 (it) * 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
EP2524919A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids
EP2524920A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Asenapine Hydrochloride Salt Forms
EP2524921A1 (en) 2011-05-17 2012-11-21 Sandoz AG Novel Crystalline Salts of Asenapine
US9533994B2 (en) 2011-05-18 2017-01-03 Laboratorios Lesvi S.L. Monoclinic crystalline form of asenapine maleate with a specific particle size distribution
US9505771B2 (en) * 2011-05-18 2016-11-29 Laboratories Lesvi S.L. Stable micronised monoclin form of asenapine maleate and its synthesis
WO2013041604A1 (en) 2011-09-21 2013-03-28 Sandoz Ag Crystal form of asenapine maleate
EP2572703A1 (en) 2011-09-21 2013-03-27 Hexal AG Compressed oral dosage form for asenapine maleate
PT2878300T (pt) * 2012-07-26 2017-08-01 Hisamitsu Pharmaceutical Co Penso
ITMI20121810A1 (it) 2012-10-24 2014-04-25 Chemo Iberica Sa Poliformi di maleato di asenapina e processo per la loro preparazione
WO2014090386A1 (en) 2012-12-11 2014-06-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Orally disintegrating tablet containing asenapine
WO2014127786A1 (en) 2013-02-22 2014-08-28 Zentiva, K.S. Orally disintegrating pharmaceutical composition comprising asenapine
EP3350194A4 (en) 2015-09-02 2019-04-24 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
KR102614709B1 (ko) 2016-12-20 2023-12-18 에르테에스 로만 테라피-시스테메 아게 아세나핀 및 폴리실록산 또는 폴리이소부틸렌을 함유하는 경피흡수 치료 시스템
PL3338768T3 (pl) 2016-12-20 2020-05-18 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
EP3644973B1 (en) 2017-06-26 2021-03-24 LTS LOHMANN Therapie-Systeme AG Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
CA3101420A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
DE69502939T2 (de) * 1994-03-02 1998-10-22 Akzo Nobel Nv Sublinguales oder bukkales arzneimittel
AU2418499A (en) * 1997-12-19 1999-07-12 Akzo Nobel N.V. Org-5222 in the treatment of depression
TWI327915B (en) * 2003-06-12 2010-08-01 Organon Nv Pharmaceutical composition comprising antipsychotic agent and use of the antipsychotic agent for treating patients with overweight

Also Published As

Publication number Publication date
ATE418556T1 (de) 2009-01-15
PE20061311A1 (es) 2007-02-09
TW200722428A (en) 2007-06-16
RU2007141198A (ru) 2009-05-20
IL186355A (en) 2016-05-31
ES2318742T3 (es) 2009-05-01
KR20080005253A (ko) 2008-01-10
EP1710245B1 (en) 2007-08-22
PL1710245T3 (pl) 2008-01-31
CY1108742T1 (el) 2014-04-09
DOP2006000082A (es) 2006-11-30
IL186355A0 (en) 2008-01-20
SI1710245T1 (sl) 2007-12-31
EP1917267A1 (en) 2008-05-07
CA2603509C (en) 2013-12-03
MX2007012445A (es) 2007-11-07
JP2008534656A (ja) 2008-08-28
ATE370954T1 (de) 2007-09-15
ES2293626T3 (es) 2008-03-16
PT1710245E (pt) 2007-10-03
DE602006000080D1 (de) 2007-10-04
DK1917267T3 (da) 2009-04-14
BRPI0609741A8 (pt) 2018-03-13
PT1917267E (pt) 2009-02-04
RU2405786C2 (ru) 2010-12-10
UY29459A1 (es) 2006-11-30
DE602006004463D1 (de) 2009-02-05
TWI364423B (en) 2012-05-21
NZ562124A (en) 2010-07-30
JP5058151B2 (ja) 2012-10-24
DE602006000080T2 (de) 2008-05-15
DK1710245T3 (da) 2007-12-03
SI1917267T1 (sl) 2009-04-30
PL1917267T3 (pl) 2009-06-30
GT200600135A (es) 2006-11-07
WO2006106135A1 (en) 2006-10-12
NO340520B1 (no) 2017-05-02
RS50532B (sr) 2010-05-07
AU2006231617A1 (en) 2006-10-12
AU2006231617B2 (en) 2010-06-03
BRPI0609741A2 (pt) 2010-04-27
EP1710245A1 (en) 2006-10-11
SV2006002473A (es) 2009-11-24
NO20075142L (no) 2007-11-05
CY1106902T1 (el) 2012-09-26
MY137969A (en) 2009-04-30
EP1917267B1 (en) 2008-12-24
HN2006014095A (es) 2010-08-19
AR056306A1 (es) 2007-10-03
CA2603509A1 (en) 2006-10-12
KR101422843B1 (ko) 2014-07-24

Similar Documents

Publication Publication Date Title
HRP20070429T3 (en) Crystal form of asenapine maleate
UA93044C2 (en) urn:schemas-microsoft-com:office:smarttagsCRYSTALFORM OF ASENAPINE MALEATE
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
TW200613256A (en) Photoactive compounds
SG145694A1 (en) Novel compounds
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
WO2006105387A3 (en) Oleds utilizing direct injection to the triplet state
WO2005037198A3 (en) Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
WO2007000325A3 (de) Substituierte 1-oxa-3,8-diazaspiro[4.5]-decan-2-on-verbindungen und deren verwendung zur herstellung von arzneimitteln
ATE516291T1 (de) Thenopyrimidin-verbindungen mit fungizider aktivität
DK1753776T3 (da) Camptotheciner, som er konjugeret i 7-stillingen til cykliske peptider, som cytostatiske midler
AP2005003370A0 (en) Novel crystalline modification of the anhydrate ofboscalid.
MX2007004591A (es) Proceso para la preparacion de compuestos organicos.
GB0324210D0 (en) Organic compounds
HK1094575A1 (en) A process for the preparation of phenyltetrazole derivatives
DK1501838T3 (da) Fremgangsmåde til fremstilling af clopidogrel
TW200606166A (en) Compounds containing 3,4-methylenedioxythiophene units
IL182575A0 (en) On-resin peptide cyclization
AU2003288173A1 (en) Safety element exhibiting properties activable by energy supply
WO2005112978A3 (en) Methods and compositions related to delivery of chemical compounds to invertebrate embryos
HU0402571D0 (en) Corn-growing by trench cultivation
AU2007906414A0 (en) Base 'brick' river to other white stones flushes.......flushed......
GB0514615D0 (en) Organic compounds
GB0303560D0 (en) Azimuthal mean time dial